All news

MPLT CFO sells 10,167 shares, stake cut 6.67%

Alpha Vantage · MarketBeat · · AI-summarised by FinFlash

Maplight Therapeutics CFO Jonathan Gillis sold 10,167 NASDAQ:MPLT shares for $82,149.36 to cover tax-withholding obligations tied to vested equity awards. The sale cut his position by 6.67%, leaving him with 142,315 shares. The stock trades near its 52-week low and well below its moving averages, though analysts keep a "Moderate Buy" rating and a $29.50 consensus target.

Read original source

MPLT company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.